Sanakin Technology in Dermatology

Autologous immune proteins for inflammation regulation and regeneration of the skin

Completely autologous treatment of inflammation of the skin with ACRS

​Using the specially developed Sanakin Technology, an Autologous Cytokine Rich Serum (ACRS) is produced from the patient’s blood. The effect of ACRS is based on the multiplication of the body’s own anti-inflammatory interleukins and growth factors. For this reason, our technology is a valuable tool for dermatologists to treat all types of skin inflammation with a completely autologous and thus very well tolerated therapy.

ACRS contains high concentrations of positive interleukins to regulate inflammation as well as growth factors. These growth factors play a crucial role in tissue regeneration. The finished serum is injected precisely into the skin areas where inflammation is to be regulated and tissue regeneration is to be supported.

In order to ensure a high level of tolerance, no artificial additives are used.

Please register in the Sanakin Information and Service Portal for comprehensive information and onboarding.

Creation of the Autologous Cytokine Rich Serum (ACRS)

1. Blood Collection

2. Incubation

3. Centrifugation

4. Application

Sanakin Technology in Dermatology – Autologous immune proteins for inflammation regulation and regeneration of the skin

100% autologous, unlimited and safe

Natural and safe procedure

Support of the body’s own regenerative powers

Very good tolerance

No overdose possible

Unlimited therapy duration

Improvement of the quality of life

Uncomplicated handling

Fast application possibility

Individual treatment by the physician

Further fields of application in the area of the skin

Wounds

Aesthetics

Please register in the Sanakin Information and Service Portal for comprehensive information and onboarding.